论文信息 - Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation. - 字舞流文

Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation.

K. Sleegers | C. van Broeckhoven | J. Adjaye | Elise Cuyvers | Martina Bohndorf | Wasco Wruck | Friederike Schröter

[1] P. Deyn,et al. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia , 2014, Neurobiology of Aging.

[2] Rui Huang,et al. SQSTM1 mutations in Han Chinese populations with sporadic amyotrophic lateral sclerosis , 2014, Neurobiology of Aging.

[3] Hans R. Schöler,et al. Small Molecule-Assisted, Line-Independent Maintenance of Human Pluripotent Stem Cells in Defined Conditions , 2012, PloS one.

[4] H. Lehrach,et al. Mitochondrial-Associated Cell Death Mechanisms Are Reset to an Embryonic-Like State in Aged Donor-Derived iPS Cells Harboring Chromosomal Aberrations , 2011, PloS one.

[5] J. Adjaye,et al. A Cyclic AMP Analog, 8-Br-cAMP, Enhances the Induction of Pluripotency in Human Fibroblast Cells , 2011, Stem Cell Reviews and Reports.

[6] Yasuko Matsumura,et al. A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[7] K. Sleegers,et al. Lymphoblast-derived integration-free iPS cell line from a 65-year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant. , 2016, Stem cell research.

[8] K. Sleegers,et al. Lymphoblast-derived integration-free iPS cell line from a 69-year-old male. , 2016, Stem cell research.